Title: Michelle Beidelschies: Innovator in Cardiovascular Risk Assessment
Introduction: Michelle Beidelschies is an accomplished inventor based in Medina, OH (US). She is currently associated with Cleveland HeartLab, Inc., where she focuses on innovations related to cardiovascular health. Although she has not yet been granted any patents, her work is significant in the field of predicting cardiovascular events.
Latest Patent Applications: Michelle's notable patent application is titled "Compositions and methods for predicting cardiovascular events." This invention provides compositions, devices, kits, and methods for determining the risk of peri-operative cardiovascular events or predicting cardiovascular events associated with angioplasty. The application outlines methods and compositions configured for determining the value of at least two markers selected from myeloperoxidase (MPO), an F2-isoprostane (F2-IsoP), C-reactive protein (CRP), urinary micro-albumin (UMA), and lipoprotein-associated phospholipase A2 (Lp-PLAZ). These innovations aim to assess a subject's risk of experiencing a cardiovascular event effectively.
Conclusion: Michelle Beidelschies is making strides in the field of cardiovascular health through her innovative approaches and research. Her contributions, although not yet reflected in granted patents, hold promise for advancing the understanding and prediction of cardiovascular events.